Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXRα signaling pathway (Q47220544)
Jump to navigation
Jump to search
scientific article published on 30 October 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXRα signaling pathway |
scientific article published on 30 October 2017 |
Statements
1 reference
Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXRα signaling pathway (English)
1 reference
Min-Jie Lin
1 reference
Wen Dai
1 reference
Melanie J Scott
1 reference
Rong Li
1 reference
Yi-Qi Zhang
1 reference
Yang Yang
1 reference
Lu-Zhu Chen
1 reference
Xian-Sheng Huang
1 reference
30 October 2017
1 reference
1 reference
8
1 reference
65
1 reference
108802-108809
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference